Guidance and Procedures for Implementing Tariff Adjustments for Specialty Pharmaceuticals and Associated Pharmaceutical Ingredients and Technical Corrections to

High · U.S. Bureau of Industry and Security · 2026-09-27

U.S. Bureau of Industry and Security · verified 2026-09-27

What happened?

This notice defines the pharmaceutical products and lists the jurisdictions that are eligible to receive an ad valorem tariff rate of zero pursuant to Presidential Proclamation 11020 of April 2, 2026, &quot;Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States,&quot; (Proclamation 11020). These pharmaceutical products include drugs and associated ingredients where all approved indications are designated as orphan; nuclear medicines; plasma derived the Verified via U.S. Bureau of Industry and Security (Wed, 23 Se) · reliability 5/5. Geographic focus: United States. Industry relevance: Cross-border Trade. Canonical official source: https://www.federalregister.gov/documents/2026/09/23/2026-19498/guidance-and-procedures-for-implementing-tariff-adjustments-for-specialty-pharmaceuticals-and.

Who is affected?

Importer
Distributor

Why does it matter?

Business Impact · High

Duty treatment covered by “Guidance and Procedures for Implementing Tariff Adjustments for Specialty Pharmaceuticals and Associated Pharmaceutical ” may change landed-cost assumptions for United States; recalculate only after confirming scope and effective date in the official text. Importers of the covered goods can re-check landed cost and the effective date of the new measure — do not assume SKU scope beyond the official notice.

Read the U.S. Bureau of Industry and Security official text first. Confirm product scope and effective date in the official text before repricing.

What should I do next?

Confirm product scope and effective date in the official text before repricing.

Confirm product scope and effective date in the official text before repricing.
Open and archive the official source link

Workspace watchlist

Follow affected entities

United States

Business impact matrix

Business impact by country and industry.

Country	Industry	Level	Note
United States	Cross-border Trade	High	Duty treatment covered by “Guidance and Procedures for Implementing Tariff Adjustments for Specialty

Background detail

What Changed Guidance and Procedures for Implementing Tariff Adjustments for Specialty Pharmaceuticals and Associated Pharmaceutical Ingredients and Technical Corrections to the Harmonized Tariff Schedule of the United States for Duties Imposed Under Proclamation 11020

What Happened Guidance and Procedures for Implementing Tariff Adjustments for Specialty Pharmaceuticals and Associated Pharmaceutical Ingredients and Technical Corrections to the Harmonized Tariff Schedule of the United States for Duties Imposed Under Proclamation 11020. Official publication from U.S. Bureau of Industry and Security dated Wed, 23 Se. Official link: https://www.federalregister.gov/documents/2026/09/23/2026-19498/guidance-and-procedures-for-implementing-tariff-adjustments-for-specialty-pharmaceuticals-and.

Who Is Affected Importers and distributors bringing covered goods into United States.

Why It Matters Duty treatment covered by “Guidance and Procedures for Implementing Tariff Adjustments for Specialty Pharmaceuticals and Associated Pharmaceutical ” may change landed-cost assumptions for United States; recalculate only after confirming scope and effective date in the official text.

What To Check Confirm product scope and effective date in the official text before repricing.

Importer Advice Importers of the covered goods can re-check landed cost and the effective date of the new measure — do not assume SKU scope beyond the official notice.

Recommended Actions - Confirm product scope and effective date in the official text before repricing. - Open and archive the official source link

Verified Sources - **U.S. Bureau of Industry and Security** (government, ★★★★★) — [Official link](https://www.federalregister.gov/documents/2026/09/23/2026-19498/guidance-and-procedures-for-implementing-tariff-adjustments-for-specialty-pharmaceuticals-and) · retrieved 2026-09-27T11:39:59.704Z · confidence 97

Timeline - 2026-09-27: Discovered by Intelligence Factory - Wed, 23 Se: Official source retrieved

Affected Countries - United States

Affected Industries - Cross-border Trade

References - U.S. Bureau of Industry and Security: https://www.federalregister.gov/documents/2026/09/23/2026-19498/guidance-and-procedures-for-implementing-tariff-adjustments-for-specialty-pharmaceuticals-and

Last Updated 2026-09-27

Confidence 97%

Intelligence · Policies · High